TEGRAMIS Trademark

Trademark Overview

On Tuesday, July 10, 2001, a trademark application was filed for TEGRAMIS with the United States Patent and Trademark Office. The USPTO has given the TEGRAMIS trademark a serial number of 76282892. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, April 30, 2003. This trademark is owned by Human Genome Sciences, Inc.. The TEGRAMIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in promoting the growth and repair of epithelial cells; Pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases or injuries, bone marrow or stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, critical care, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic diseases, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurologic disorders, nutritional disorders, obstetric, gynecological and reproductive disorders, occupational injuries, oncology, ophthalmologic diseases, organ transplantation, pancreatic disorders, poisoning, psychiatric disorders, respiratory diseases, dermatologic disorders, sports injuries, substance abuse disorders, thrombotic diseases, traumatic injuries, vascular d...
tegramis

General Information

Serial Number76282892
Word MarkTEGRAMIS
Filing DateTuesday, July 10, 2001
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, April 30, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 6, 2002

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in promoting the growth and repair of epithelial cells; Pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases or injuries, bone marrow or stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, critical care, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic diseases, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurologic disorders, nutritional disorders, obstetric, gynecological and reproductive disorders, occupational injuries, oncology, ophthalmologic diseases, organ transplantation, pancreatic disorders, poisoning, psychiatric disorders, respiratory diseases, dermatologic disorders, sports injuries, substance abuse disorders, thrombotic diseases, traumatic injuries, vascular diseases, and wounds

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 20, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHuman Genome Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameHuman Genome Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Thursday, August 7, 2003ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 29, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2002PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2002NOTICE OF PUBLICATION
Saturday, April 20, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 20, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 19, 2001NON-FINAL ACTION MAILED
Tuesday, August 28, 2001ASSIGNED TO EXAMINER

Related Keywords

tegramis diseases disorders injuries conditions transplantation pharmaceutical bone preparations obstetric nutritional